14 papers
Time restricted
14 publications — 6 trials, 5 syntheses.
Hvað þessi síða byggir á, efni fyrir efni: hversu margar greinar, hversu margar eru rannsóknir, og hversu nýjar. Myndað úr uppskerunni, þannig að það getur ekki farið frá tilvísunum sjálfum.
14 papers
14 publications — 6 trials, 5 syntheses.
13 papers
13 publications — 3 trials, 7 syntheses.
12 papers
12 publications — 4 trials, 4 syntheses.
10 papers
10 publications — 2 trials, 6 syntheses.
10 papers
10 publications — 3 trials, 6 syntheses.
9 papers
9 publications — 3 trials, 5 syntheses.
9 papers
9 publications — 5 trials, 1 synthesis.
8 papers
8 publications — 3 trials, 3 syntheses.
7 papers
7 publications — 1 trial, 5 syntheses.
What the trials actually show about semaglutide, tirzepatide and the rest of the GLP-1 class.
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep, circadian rhythm and the wearables that claim to measure both.
Þessi síða var þýdd sjálfkrafa úr ensku. Tilvísanir og tölur eru óbreyttar. Lestu upprunalega ensku ef eitthvað hljómar undarlega. Lestu upprunalega ensku